Better weight seen in phentermine/topiramate-treated patients

12/28/2011 | Endocrine Today

Adding controlled release phentermine/topiramate to a lifestyle modification program helped induce significant and sustained weight loss in patients at 108 weeks compared with those who took a placebo, researchers at the University of Alabama at Birmingham found. The treatment was also associated with improved cardiovascular and metabolic variables and lower diabetes rates in patients, according to the study in the American Journal of Clinical Nutrition.

View Full Article in:

Endocrine Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR